Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Timex Group India Ltd.
Swot
Timex Group India Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Timex Group India Ltd. has 16 Strengths, 8 Weaknesses, 2 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(16)
Weakness
(8)
Opportunity
(2)
Threats
(0)
Others
(3)
Benjamin Graham Value Screen
Companies with 10% increase in share price over three months, with rising net profit growth
Upcoming results for Nifty500 companies with previous quarter net profit growth greater than 10% YoY and QoQ
Relative Outperformance versus Industry over 1 Year
Companies with high TTM EPS Growth
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Overbought by Money Flow Index (MFI)
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Negative to Positive growth in Sales and Profit with Strong Price momentum
Stocks Outperforming their Industry Price Change in the Quarter
Companies with growing costs YoY for long term projects
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Declining Net Cash Flow : Companies not able to generate net cash
Increasing Trend in Non-Core Income
RSI indicating price weakness
Top Losers
Companies with Upcoming Results
FII / FPI or Institutions increasing their shareholding
Rising Delivery Percentage Compared to Prev Day
Expensive Performers (DVM)
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks